Relapsed refractory multiple myeloma with CNS involvement successfully treated with Elranatamab: first reported case

Central nervous system (CNS) involvement in multiple myeloma (MM) is a rare and challenging complication associated with poor prognosis and limited treatment options. Emerging T-cell directing therapies, such as bispecific antibodies (bsAbs) and chimeric antigen receptor T cells (CAR-T), have shown...

Descripció completa

Dades bibliogràfiques

Autors principals:	Yasa Gul Mutlu, Sureyya Yıgıt Kaya, Senem Maral, Elif Melek, Zafer Baslar, Leylagul Kaynar, Omur Gokmen Sevindik
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2023-10-01
Col·lecció:	Frontiers in Immunology
Matèries:	Elranatamab multiple myeloma bispecific Ab BCMA CNS involvement
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1276295/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!